NCT04765787View on ClinicalTrials.gov

Safety & Efficacy of Nuberol Forte® in Pain Management

CompletedOBSERVATIONAL

Enrollment

399

Participants

Timeline

Start Date

November 25, 2020

Primary Completion Date

April 1, 2021

Study Completion Date

August 1, 2021

Conditions

Musculoskeletal DisorderPain Management

Interventions

DRUG

Combination of Paracetamol 650mg + Orphenadrine 50mg

In routine practice for pain , combination of Paracetamol 650 mg + Orphenadrine 50mg prescribed for 7-10 days with follow up and as per physician discretion

Trial Locations (3)

Unknown

Liaquat National Hospital, Karachi

Medicare Hospital, Karachi

Patel Hospital, Karachi

All Listed Sponsors

lead

The Searle Company Limited Pakistan

INDUSTRY

NCT04765787 - Safety & Efficacy of Nuberol Forte® in Pain Management | Biotech Hunter | Biotech Hunter